Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) – Analysts at Oppenheimer boosted their FY2023 earnings per share estimates for shares of Simulations Plus in a research note issued to investors on Thursday, April 6th. Oppenheimer analyst F. Brisebois now forecasts that the technology company will post earnings per share of $0.66 for the year, up […]
Simulations Plus (NASDAQ:SLP – Get Rating)‘s stock had its “outperform” rating reaffirmed by investment analysts at Oppenheimer in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $65.00 price target on the technology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 53.66% from the company’s […]
Drug discovery services partnership with Sino-American Cancer Foundation focuses on the development of actionable hits against the MTHFD2 target
. | March 28, 2023
Wall Street brokerages expect Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) to post $14.12 million in sales for the current quarter, according to Zacks. Two analysts have made estimates for Simulations Plus’ earnings, with the lowest sales estimate coming in at $13.96 million and the highest estimate coming in at $14.28 million. Simulations Plus reported […]
Wall Street analysts forecast that Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) will report sales of $14.12 million for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Simulations Plus’ earnings, with estimates ranging from $13.96 million to $14.28 million. Simulations Plus reported sales of $12.78 million during the same quarter […]